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Abstract Efficiency of Fas-mediated apoptosis of lymphoid
cells is regulated, among other means, by a mechanism involving
its association with ezrin, a cytoskeletal protein belonging to the
4.1 family of proteins. In the present work, we provide evidence
for a further molecule that associates to ezrin in Fas-triggered
apoptosis, the disialoganglioside GD3. In fact, as an early event,
GD3 redistributed in membrane-associated domains in uropods
and co-localized with ezrin. Co-immunoprecipitation analyses
confirmed this result, indicating a GD3^ezrin association.
Altogether, these results are suggestive for a role of GD3 in
Fas/ezrin-mediated apoptosis, supporting the view that uropods
contain a multimolecular signaling complex involved in Fas-
mediated apoptosis. ß 2001 Federation of European Biochem-
ical Societies. Published by Elsevier Science B.V. All rights
reserved.
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1. Introduction
It was hypothesized that apoptosis could be mediated by
two di¡erent pathways that, although strictly intertwined,
may represent di¡erent ways to reach the same result, i.e.
the death of a cell [1,2]. The ¢rst pathway (type I) is consis-
tently exerted by those cells that follow the CD95/Fas-medi-
ated apoptosis initiated by active caspase 8 and ¢nally leading
to an execution phase cascade. This pathway involves mito-
chondria only in the late phases of the apoptotic cascade. In
contrast, the second pathway (type II) is the mitochondrial
branch of the apoptotic pathway where this organelle might
play a primary role [2]. We have recently shown [3] that hu-
man T cells, that are susceptible to Fas-mediated apoptosis,
exhibit a constitutive polarized morphology forming uropods
with distinct plasma membrane domains. We also suggested
that Fas polarization, through an ezrin-mediated association
with the actin cytoskeleton, is a key intracellular mechanism
in the regulation of Fas-mediated apoptotic signal [3].
Glycosphingolipids (GSLs), carbohydrate-bearing lipid
components of biological membranes, have been implicated
as mediators of cell adhesion as well as modulators of signal
transduction [4]. In particular, gangliosides, sialic acid-con-
taining GSLs, are considered to have a role as recognition
sites that may mediate the interaction of the cell with its
surroundings and play an important role in cell adhesion,
di¡erentiation and immune modulation [4,5]. The cell expres-
sion pattern of gangliosides depends on the cell type: in hu-
man lymphocytes, monosialoganglioside GM3 is the major
ganglioside constituent [6], and disialoganglioside GD3,
although in minor extent, is also well expressed [7]. Recently,
we have observed that a GD3 overexpression in activated
lymphocytes was strictly associated with the early events lead-
ing to cell depletion by apoptosis [8]. This increase appeared
to be accompanied by qualitative changes, i.e. intracellular
redistribution of GD3 molecules in typical lymphocyte struc-
tures called uropods [3,8]. Accordingly, we and others hy-
pothesized that a portion of intracellular GD3 can play a
role in apoptotic machinery [8,9]. However, although GD3
has been reported to propagate Fas-mediated apoptotic sig-
nals in myeloid tumor cells [10,11], and to be involved in
mitochondrial-mediated apoptosis [9], either the mechanisms
upstream of the ganglioside action and its direct targets still
remain to be elucidated. On the basis of these considerations,
we decided to analyze the role of GD3 in ezrin/Fas-mediated
apoptosis in a human T lymphoblastoid cell line (CEM cells).
The results obtained allow to hypothesize that uropods can
represent a cell death key structure where a series of molecular
and functional associations, i.e. of death-related molecules
Fas, ezrin and GD3, probably have to take place.
2. Materials and methods
2.1. Cells
Human lymphoblastoid CEM cells were cultured in RPMI 1640
(Gibco-BRL, Life Technologies Italia srl, Milan, Italy) containing
10% fetal calf serum at 37‡C in a humidi¢ed 5% CO2 atmosphere.
2.2. Induction of apoptosis
Anti-human CD95 treatment: 250 ng/ml of an anti-human IgM
mAb (clone CH11, Upstate Biotechnology, Lake Placid, NY, USA)
was added to CEM cell cultures (5U105 cells/ml) for di¡erent time
periods (10 min, 3 h, 4 h, 6 h). After treatment, cells were collected,
washed and analyzed for apoptosis. Staurosporine (STS) treatment:
the protein kinase inhibitor staurosporine (Sigma Chem Co., St.
Louis, MO, USA) was added to the culture medium at the ¢nal con-
centration of 1 WM [12]. After 4 h treatment, control and treated cells
were prepared for £uorescence, scanning electron microscopy (SEM)
and co-immunoprecipitation.
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2.3. Cytochalasin D (CD) treatment
Control and treated cells were exposed to CD (Sigma) before di¡er-
ent apoptotic inducers. The CD concentration used in this study
(0.5 Wg/ml) inhibits actin polymerization without being cytotoxic, as
assessed by analytical cytology analyses [13].
2.4. SEM analysis
CEM cells were ¢xed with 2.5% (v/v) glutaraldehyde in 0.1% caco-
dylate bu¡er (pH 7.4) and processed as previously described [14].
Samples were then examined with a Cambridge 360 SEM.
2.5. Immuno£uorescence and intensi¢ed video microscopy (IVM)
Control and treated cells were collected by centrifugation, allowed
to attach to glass coverslips pre-coated with polylysine and ¢xed with
4% paraformaldehyde in phosphate-bu¡ered saline (PBS) for 30 min
at room temperature. After washing in the same bu¡er, the cells were
permeabilized with 0.5% Triton X-100 in PBS for 5 min at room
temperature. For localization of CD95 and ezrin, samples were incu-
bated at 37‡ for 30 min with polyclonal antibodies to CD95 (Santa
Cruz Biotechnology, CA, USA) or monoclonal antibodies to ezrin,
(Transduction Laboratories, Lexington, KY, USA). Cells were then
incubated with TRITC-conjugated anti-rabbit IgG (Sigma) or FITC-
conjugated anti-mouse IgG (Sigma) for detection of CD95 and ezrin
proteins, respectively. Alternatively, the cells were incubated with
GMR2 anti-GD3 mAb [8,15], a gift from Dr. T. Tai, Tokyo Metro-
politan Institute of Medical Science, Tokyo, Japan, for 1 h at 37‡C.
This antibody showed highly restricted binding speci¢city, reacting
only with the immunizing ganglioside. None of other gangliosides
or neutral glycolipids were recognized [15]. This incubation was fol-
lowed by the addition of FITC-conjugated anti-mouse IgM (Sigma)
for 30 min at 37‡C. After washing, all samples were mounted with
glycerol^PBS (2:1) and observed with a Nikon Microphot £uores-
cence microscope. IVM images were obtained by a chilled color
3CCD camera (Hamamatsu, Japan). Normalization and background
subtraction were performed for each image. Figures were obtained by
the OPTILAB (Graftek, France) software for image analysis.
2.6. Scanning confocal microscopy
Anti-CD95-treated and untreated CEM cells were ¢xed as reported
above, or alternatively, incubated in the presence of acetone^methanol
1:1 (v/v) for 10 min at 4‡C and then soaked in balanced salt solution
(Sigma) for 30 min at room temperature. Cells were then labeled with
anti-GD3 mAb for 1 h at 4‡C, followed by addition with FITC-con-
jugated goat anti-mouse IgM (Sigma) for 45 min at 4‡C. After wash-
ing with PBS at 4‡C, cells were then counterstained with monoclonal
antibody to ezrin (Biogenesis, UK), followed by the addition of Texas
red-conjugated anti-mouse IgG (Sigma) for 30 min at 4‡C. The cel-
lular distribution of GD3 molecules was analyzed by scanning con-
focal microscopy. Images were acquired through a laser scanning
confocal microscope Zeiss LSM 510 (Zeiss, Oberkochen, Germany)
equipped with argon and HeNe ion lasers. Simultaneously, the green
(FITC) and the red (Texas red) £uorophores were excited at 488 and
518 nm and were observed by two di¡erent detectors. Images were
collected at 1024U1024 pixels.
2.7. Evaluation of apoptosis
Apoptosis was evaluated by morphometric analyses and by £ow
cytometry. To assess nuclear morphology, cells ¢xed in paraformal-
dehyde, were dyed with Hoechst 33258 (10 Wg/ml) for 30 min at 37‡C.
Slides were rinsed in PBS and mounted with glycerol^PBS (2:1) and
observed with a Nikon Microphot £uorescence microscope. Quanti-
tative evaluation of apoptotic cells was performed by counting at least
300 cells at a 50U magni¢cation. DNA fragmentation was studied by
propidium iodide (PI) staining followed by £ow cytometric analysis
(EPICS Pro¢le, Coulter Electronics, Hialeah, FL, USA). Cells were
¢xed with cold 70% ethanol in PBS for 1 h at 4‡C. After centrifuga-
tion at 200Ug for 10 min at 4‡C, cells were washed once in PBS. The
pellet was resuspended in 0.5 ml PBS, 50 Wl of RNAse (type I-A;
Sigma; 10 mg/ml in PBS) was added, followed by 1 ml PI (Sigma;
100 Wg/ml in PBS) solution. The cells were incubated in the dark at
room temperature for 15 min and kept at 4‡C in the dark until mea-
sured. A Trypan blue exclusion test was performed to evaluate the
viability of the cultures.
2.8. Co-immunoprecipitation and high-performance thin-layer
chromatography (HPTLC) analysis of ganglioside extracts
GD3^protein association was analyzed by co-immunoprecipitation
as described [16]. Brie£y, ¢rst, anti-CD95-treated, STS-treated or un-
treated CEM cells were lysed in lysis bu¡er (20 mM HEPES, pH 7.2,
1% Nonidet P-40, 10% glycerol, 50 mM NaF, 1 mM phenylmethyl-
sulfonyl £uoride, 10 Wg of leupeptin per ml). Then, cell-free lysates
were mixed with protein G-acrylic beads and stirred by a rotary
shaker for 2 h at 4‡C to pre-clear non-speci¢c binding. After centri-
fugation (500Ug for 1 min), the cleared supernatant was immunopre-
cipitated with anti-ezrin mAb (Biogenesis, UK) plus protein G-acrylic
beads. As a negative control, a mouse IgG with irrelevant speci¢city
(Sigma) was employed. The immunoprecipitates were then subjected
to ganglioside extraction, according to the method of Svennerholm
and Fredman [17], with minor modi¢cations. Brie£y, immunoprecipi-
tates were extracted twice in chloroform:methanol:water (4:8:3, v/v)
and subjected to Folch partition by the addition of water to give a
¢nal chloroform:methanol:water ratio of 1:2:1.4. The upper phase,
containing polar GSLs, was desalted and low molecular weight con-
taminants were removed using Supelclean LC-18 tubes (Supelco Inc.,
Bellefonte, PA, USA), according to the method of Williams and
McCluer [18]. The eluted GSLs were dried and separated by HPTLC,
using silica gel 60 HPTLC plates (Merck, Darmstadt, Germany).
Chromatography was performed in chloroform:methanol:0.25%
aqueous KCl (5:4:1, v:v). Plates were air-dried and gangliosides vi-
sualized with resorcinol [19]. Densitometric scanning analysis was
performed by Mac OS 9.0 (Apple Computer International), using
NIH Image 1.62 software.
To identify ganglioside molecule(s) co-migrating with GD3, TLC
immunostaining was performed on aluminum-backed silica gel plates
(Merck, Darmstadt, Germany), as previously described [20], using the
anti-GD3 mAb GMR2 [15].
In order to verify the immunoprecipitation of ezrin molecules, a
portion of the immunoprecipitates was run on 10% SDS^PAGE
and then probed with polyclonal anti-ezrin Ab (Santa Cruz Biotech
Inc., Santa Cruz, CA, USA). Bound antibodies were then visualized
with peroxidase-conjugated anti-goat IgG (Sigma), and immunoreac-
tivity assessed by chemiluminescence reaction using the ECL Western
blocking detection system (Amersham, Buckinghamshire, UK).
3. Results
3.1. Fas, ezrin and GD3 polarization in uropod-forming cells
We ¢rst evaluated the cellular distribution of Fas, ezrin and
GD3 molecules in CEM lymphoblastoid cells by immuno£uo-
rescence microscopy. We found that both Fas and ezrin (Fig.
1a,b) were mainly observable as plasma-membrane-associated
domains in the apical portion of uropods of CEM cells which,
by SEM analyses, appeared as large bulbs forming long cell
protrusions (Fig. 1c). By contrast, the anti-GD3 signal, after
Triton X-100 extraction, appeared as a punctate positivity
throughout the cell cytoplasm including uropods (Fig. 1d).
When experiments on CD95/Fas-mediated apoptotic trigger-
ing were carried out, a rearrangement of GD3 distribution
was detected by IVM observations. In fact, ganglioside mol-
ecules were mainly found in the uropod (Fig. 1e). Moreover,
this redistribution appeared to depend upon the integrity of
actin ¢lament network. In fact, when cells were pre-treated
with CD, an inhibitor of actin polymerization used at low,
non-cytotoxic concentrations [3], an inhibition of apoptosis as
well as no sign of GD3 polarization were detected (Fig. 1f).
3.2. GD3 distribution in uropod-forming cells
Since apoptosis is a ‘dynamic’ process, we decided to eval-
uate the time-course of the above described phenomena. In
particular, GD3 analytical cytology studies were carried out at
di¡erent times after anti-Fas treatment (up to 4 h). Fig. 2
shows the progressive rearrangement and redistribution of
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GD3 molecules forming clumps towards the cell periphery
(Fig. 2a^c). After 4 h, the ganglioside staining is mainly de-
tected in the uropods (Fig. 2d). Notably, apoptosis evaluation
clearly indicated that Fas-mediated apoptosis in our experi-
mental conditions led to high rates of cell death only after 4^6
h (Fig. 2g). Hence, redistribution of GD3 appeared to occur
as an early event. Finally, in consideration of the di¡erent
mechanisms employed by various apoptotic stimuli, the e¡ects
of a di¡erent apoptotic inducer, i.e. STS, was also assessed.
This drug is in fact targeted to mitochondria and, unlike Fas
(type I), it is considered as a typical type II inducer [2]. In this
case no rearrangement of GD3 was detected (Fig. 2f).
3.3. GD3^ezrin co-localization in Fas-triggered CEM cells
To investigate whether GD3 and ezrin polarization resulted
in a direct interaction within speci¢c domains of CEM cells,
we analyzed their distribution by scanning confocal microsco-
py and superimposed the double-immunostaining patterns ob-
tained by using anti-GD3 and anti-ezrin antibodies. Our re-
sults showed that in cells incubated with anti-CD95/Fas for
4 h, the GD3 signal appeared localized on the cell surface and
intracellularly, resembling speci¢c cytoplasmic compart-
ment(s). The anti-GD3 staining appeared mainly con¢ned to
the uropods (Fig. 3a,e). In the same cells, the anti-ezrin stain-
ing was also present within uropods (Fig. 3b,f). Merging of
the images of anti-GD3 and anti-ezrin staining showed a
nearly complete overlap, as indicated by the yellow areas.
This indicates that ezrin molecules were localized in cell pro-
trusions (uropods) enriched with GD3 molecules (Fig.
3c,d,g,h).
Fig. 1. IVM of CEM cells. The presence of Fas (a) as well as ezrin (b) molecules in the uropod of CEM cells is well visible. A SEM micro-
graph displaying ultrastructural features of a typical uropod is shown in (c). GD3 molecules appear randomly distributed in the cell, including
uropod of Triton-permeated cells (d). Fas treatment induced an increased presence of GD3 in the uropod (e). After cytochalasin B treatment,
the uropod appears as a GD3-negative structure (f, arrows indicate the uropod). Magni¢cation 1716U.
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3.4. GD3 co-immunoprecipitates with ezrin in FAS-triggered
CEM cells
To verify whether GD3 binds directly to ezrin, cell-free
lysates from anti-Fas-treated and untreated CEM cells were
immunoprecipitated with the anti-ezrin mAb, followed by
protein G-acrylic beads. Acidic GSLs were then extracted
from the ezrin immunoprecipitates. They were then analyzed
by and HPTLC, which showed a disialoganglioside GD3 co-
migrating band in the extracts from anti-Fas-treated cells (4 h)
(Fig. 4, lane a). A tiny band co-migrating with GM3 was also
observed, suggesting the presence of a small amount of GM3.
The GM3 double band is due to the heterogeneity of fatty
acid composition. In these cells (treated with anti-Fas for 4 h)
we observed: (i) GD3 content in the immunoprecipitate was
2.42-fold as compared to GM3, as detected by densitometric
analysis (Fig. 4); (ii) the total content of the two gangliosides
was about 4 Wg of GM3/108 and 0.4 Wg of GD3/108 cells, as
detected by measuring the lipid-bound sialic acid. Thus, GD3
resulted in about 24-fold enriched in the ezrin immunopreci-
pitates in comparison to GM3. No resorcinol-positive bands
were detectable in the immunoprecipitates from cells treated
with anti-Fas for 10 min (Fig. 4, lane b), cells treated with
STS (Fig. 4, lane c), or in untreated cell extracts (Fig. 4, lane
d). In control samples, the immunoprecipitation with a mouse
IgG, with irrelevant speci¢city, under the same conditions did
not result in detectable levels of GD3 or GM3 (Fig. 4, lane e).
The identity of GD3 was con¢rmed by immunostaining on
TLC of the immunoprecipitates with the GMR2 mAb (Fig.
Fig. 2. IVM of Fas-treated CEM cells. Time-course analysis indicating the time-dependent redistribution of GD3 in the uropods (a^d). Note
that the presence of GD3 in the uropods appears to be related to the increased apoptotic ratio found after 4 h of Fas exposure (g). STS apo-
ptotic stimulus exposure did not induce GD3 redistribution (f).
FEBS 25182 26-9-01 Cyaan Magenta Geel Zwart
A.M. Giammarioli et al./FEBS Letters 506 (2001) 45^5048
4, lane g). Again, no anti-GD3-positive bands were detectable
in untreated cell extracts (Fig. 4, lane h).
4. Discussion
Mechanisms of apoptosis have recently been investigated by
several works trying to point out the cascade of events that
follows apoptotic triggering. In the present study we show, for
the ¢rst time, that in type I, Fas-mediated apoptosis, GD3
ganglioside associates to ezrin cytoskeleton, suggesting its pos-
sible role in the very early steps of apoptotic cascade and prior
to the subsequent, late mitochondrial-mediated events [2,21].
Thus, our indications of a further activity of GD3 in apopto-
sis machinery are in agreement with previously reported data
regarding target activity of GD3 on mitochondria [9].
It was demonstrated that either pharmacological inhibition
of GD3 synthesis or cell exposure to GD3 synthase antisense
oligodeoxynucleotides prevented CD95/Fas-mediated apopto-
sis [10]. On the other hand, ezrin antisense oligonucleotides
hindered Fas-mediated apoptosis, indicating the requirement
of actin-cytoskeleton integrity and function in the Fas-medi-
ated cascade leading to cell death [3]. It was also hypothesized
that GD3 ganglioside could mediate the ‘propagation’ of Fas-
generated pro-apoptotic signals [10]. Hence, in light of the
results reported herein, we can hypothesize that this mediation
could occur by a structural association of GD3 with ezrin
molecules. Speci¢c high-a⁄nity SDS-resistant ganglioside^
protein interactions reported in di¡erent cell types appear in
fact to be involved in transducing stimulatory and/or inhib-
itory cellular signals [22,23]. In addition, we cannot rule out
the possibility that other 4.1 family molecules, e.g. moesin or
radixin, could be similarly involved. It can also be hypothe-
sized that ezrin^GD3 molecular association can represent a
prerequisite for ganglioside cytoplasmic tra⁄cking, and that
it can ¢nally lead to the mitochondrial e¡ects previously de-
scribed in literature [9]. In fact, on the basis of our results (see
Fig. 1d) and literature data [5], the presence of gangliosides in
several subcellular structures can be taken into account.
Moreover, changes of ganglioside distribution in the cell cy-
toplasm have been suggested to be regulated by various cyto-
skeleton elements [24]. Accordingly, low concentrations of
micro¢lament perturbating agent CD not only impaired
Fas-mediated apoptosis cascade [2], but, as shown herein,
also a¡ected GD3 molecule distribution. Hence, altogether,
these ¢ndings seem to suggest that the scattered distribution
of GD3-associated Triton-insoluble domains found in control
CEM cells can be modi¢ed by CD95/Fas stimulation via an
ezrin association. This could also suggest that association with
cytoskeleton can play a key role in cytoplasmic movements of
GD3 molecule ¢nally targeted to mitochondria [9] and leading
to apoptosis.
On the other hand, a typical mitochondrially targeted drug,
such as STS, capable of directly acting on mitochondrial
membrane transition in CEM cells [25] induced neither GD3
redistribution nor GD3^ezrin association. Hence, although
several experiments have to be performed to better elucidate
this point, e.g. by using ezrin antisense oligonucleotides
(manuscript in preparation), we cannot rule out a speci¢c
activity of ezrin molecules in the e⁄ciency of earlier steps of
Fas-mediated cell death signaling via its association with GD3
gangliosides. Indeed, co-immunoprecipitation experiments re-
vealed the presence of GD3 and GM3 molecules in the ezrin
immunoprecipitate. This ¢nding, together with scanning con-
focal microscopic analyses, strongly suggest that Fas-triggered
apoptosis induces ezrin association with plasma-membrane
raft microdomains. This hypothesis is in agreement with pre-
viously suggested links between raft-mediated signaling and
the interaction of actin cytoskeleton with membrane raft do-
mains [26] and the possible role of 4.1 family proteins ezrin
and moesin in redistribution and tra⁄cking of other impor-
tant molecules in the uropods of T lymphocytes [27].
Altogether, our ¢ndings represent the ¢rst evidence of an
association between GD3 ganglioside and ezrin molecules
Fig. 3. Scanning confocal microscopic analysis of GD3^ezrin associ-
ation on a CEM plasma membrane after anti-CD95/Fas treatment.
Cells were labeled with anti-GD3 mAb (GMR2), followed by the
addition of FITC-conjugated anti-mouse IgM. Cells were then incu-
bated with anti-ezrin, followed by the addition of Texas red-conju-
gated anti-mouse IgG. Magni¢cation 1072U (pictures a^d); 512U
(pictures e^h). Fas treatment clearly induced a redistribution of
GD3 (a,e) and ezrin (b,f) within uropods; anti-GD3 and anti-ezrin
double-staining revealed yellow areas, corresponding to nearly com-
plete co-localization (c,g); dual immuno£uorescence image analysis
represents exclusively the co-localization areas of GD3^ezrin (d,h).
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after Fas triggering, suggesting that membrane raft microdo-
mains mediate lateral assemblies involved in Fas-mediated ap-
optosis. This could also be of relevance in the understanding
of the mechanisms of regulation of this cell death process [9]
in terms of both resistance and susceptibility.
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the intensity of the GD3 and GM3 co-migrating bands detected in ezrin immunoprecipitate after anti-Fas treatment (4 h). Arbitrary units; lane
b: gangliosides extracted from ezrin immunoprecipitate after anti-Fas treatment (10 min); lane c: gangliosides extracted from ezrin immunopre-
cipitate after STS treatment; lane d: gangliosides extracted from untreated ezrin immunoprecipitate; lane e: gangliosides extracted from irrele-
vant mouse IgG immunoprecipitate; lane f: standard gangliosides; lane g: GD3 immunostaining analysis on TLC from ezrin immunoprecipi-
tates of anti-Fas-treated cells ; lane h: GD3 immunostaining analysis on TLC from ezrin immunoprecipitates of untreated cells.
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